Shift4 Payments, Inc. (FOUR) Form 8-K — Nov 5, 2026

$FOURForm 8-KItems 2.02, 9.01Filed Nov 5, 2026, 7:02 AM ET0001794669-26-000049Original filing

Shift4 Payments reported Q3 2026 gross revenue of $1.319 billion, up 12% YoY, with net income of $40 million and Adjusted EBITDA of $310 million (+6% YoY). However, the company cut full-year guidance: GRLNF lowered to $2.45-2.46 billion and Adjusted EBITDA to $1.11-1.13 billion, roughly 4% and 6% below original guidance, citing travel disruptions, currency headwinds, and weak same-store sales. Adjusted Free Cash Flow guidance of $465-475 million was affirmed, with Q3 Adj. FCF a record $200 million (+42% YoY).

Key figures

Eps: 0.37
Revenue: 1319000000
Guidance: FY2026 Volume $240-250B (tightened upper end); GRLNF $2.45-2.46B (lowered); Adjusted EBITDA $1.11-1.13B (lowered ~6% vs. original); Non-GAAP EPS $5.05-5.15 (prior $5.15-5.35); Adjusted Free Cash Flow affirmed at $465-475M; Q4 GRLNF $625-640M, Adjusted EBITDA $285-300M, Non-GAAP EPS $155-165M
Net Income: 40000000
Revenue Yoy: 12%
Total Assets: 9470000000
Cash Position: 1638000000
Shares Outstanding: 77761480
Grlnf: $648M (+10% YoY; +9% organic constant currency)
Q3 volume: $61B (+11% YoY)
Q3 buybacks: 4.2M shares for $190M plus $10M of preferred shares
Gross profit: $434M (+6% YoY)
Non gaap eps: $1.49
Blended spread: 64 bps
Adjusted ebitda: $310M (+6% YoY, 48% margin)
Share price ytd: down roughly 40% since beginning of 2026
Non gaap net income: $132M
Payments based grlnf: $402M (+18% YoY)
Adjusted free cash flow: $200M (quarterly record, +42% YoY)
Net cash from operations: $221M
Tax free shopping revenue: $139M (+7% YoY)
Subscription and other revenue: $107M (-10% YoY)
Global blue synergies exit 2026: nearly $50M toward 2027 target of $70M
Remaining buyback authorization: $175M under existing authorization plus new $1B authorization approved

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $40.67/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.